Skip to content

APITOPE INTERNATIONAL: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APITOPE INTERNATIONAL

BE 0807.253.103
NACE 86.910, Medical imaging and medical laboratories
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€471,830
2024 · -€74,299+€546,128
Equity
€264,150
2024 · €42,320+€221,830
Cash
€3,038
2024 · €66,992-€63,955
Balance sheet total
€553,063
2024 · €90,825+€462,239

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€526,059

    up €526,059 (+2207.3%), from €23,832 to €549,891

    of which Trade receivables: +€525,310

  • Cash -€63,955

    down €63,955 (-95.5%), from €66,992 to €3,038

    mainly Receivables within one year (-€526,059) and Contributions, distributions and other (-€250,000)

Equity and liabilities
  • Other debts +€250,000

    up €250,000, from €0 to €250,000

  • Profit (loss) carried forward +€221,830

    up €221,830, from -€127,979 to €93,851

  • Trade debts -€9,591

    down €9,591 (-19.8%), from €48,504 to €38,913

Income statement
  • Gross operating margin +€491,762

    up €491,762, from -€16,518 to €475,244

  • Financial charges -€52,905

    down €52,905 (-95.7%), from €55,270 to €2,365

    of which Non-recurring financial charges: -€53,368

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€74,299
Gross operating margin +€491,762
Write-downs +€275
Other operating charges +€1,184
Financial income +€11
Financial charges +€52,905
Taxes -€9
Result 2025 €471,830

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€186,045
Investment €0
Financing -€250,000
Cash 2024 €66,992
Net result for the year +€471,830
Receivables within one year -€526,059
Deferred charges and accrued income -€135
Trade debts -€9,591
Other debts +€250,000
Contributions, distributions and other -€250,000
Cash 2025 €3,038
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €90,825 €553,063 +€462,239 +508.9%
Fixed assets 21/28 €0 - =
Financial fixed assets 28 €0 - =
Current assets 29/58 €90,825 €553,063 +€462,239 +508.9%
Amounts receivable within one year 40/41 €23,832 €549,891 +€526,059 +2207.3%
Trade receivables 40 €22,870 €548,180 +€525,310 +2296.9%
Other amounts receivable 41 €962 €1,710 +€748 +77.8%
Cash at bank and in hand 54/58 €66,992 €3,038 -€63,955 -95.5%
Deferred charges and accrued income 490/1 - €135 +€135
Total equity and liabilities 10/49 €90,825 €553,063 +€462,239 +508.9%
Equity 10/15 €42,320 €264,150 +€221,830 +524.2%
Contributions 10/11 €159,609 €159,609 = 0.0%
Capital 10 €159,609 €159,609 = 0.0%
Issued capital 100 €159,609 €159,609 = 0.0%
Reserves 13 €10,690 €10,690 = 0.0%
Non-distributable reserves 130/1 €10,690 €10,690 = 0.0%
Legal reserve 130 €10,690 €10,690 = 0.0%
Profit (loss) carried forward 14 -€127,979 €93,851 +€221,830
Amounts payable 17/49 €48,504 €288,913 +€240,409 +495.6%
Amounts payable within one year 42/48 €48,504 €288,913 +€240,409 +495.6%
Trade debts 44 €48,504 €38,913 -€9,591 -19.8%
Suppliers 440/4 €48,504 €38,913 -€9,591 -19.8%
Other amounts payable 47/48 €0 €250,000 +€250,000
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €275 €0 -€275 -100.0%
Other operating charges 640/8 €2,244 €1,060 -€1,184 -52.7%
Gross operating margin 9900 -€16,518 €475,244 +€491,762
Operating profit (loss) 9901 -€19,038 €474,184 +€493,221
Financial income 75/76B €0 €11 +€11 +3907.1%
Recurring financial income 75 €0 €11 +€11 +3907.1%
Financial charges 65/66B €55,270 €2,365 -€52,905 -95.7%
Recurring financial charges 65 €1,902 €2,365 +€463 +24.4%
Non-recurring financial charges 66B €53,368 €0 -€53,368 -100.0%
Profit (loss) for the period before taxes 9903 -€74,307 €471,830 +€546,137
Income taxes 67/77 -€9 €0 +€9
Profit (loss) for the period 9904 -€74,299 €471,830 +€546,128
Profit (loss) for the period to be appropriated 9905 -€74,299 €471,830 +€546,128

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.